Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG studyMartee L. Hensley, Richard P. Moser, Gustavo C. Rodriguez et al.|Gynecologic Oncology|2019Cited by 14
Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group studyL. Phuong, Mark E. Sherman, Austin Miller et al.|American Journal of Obstetrics and Gynecology|2022Cited by 5